Kwick Forensic Solutions IPO- Company Analysis
Kwick Forensic Solutions IPO under the SME IPO category is a book-built issue of Rs. 50.77 Cr by Kwick Forensic Solutions Limited, which is offering law enforcement solutions, evidence management, cyber and digital forensics, DNA forensics, and forensic science throughout India. The company first concentrated on software development, including simulation, animation, and 3D rendering.
Later, it branched out into instructional technologies and forensic science. It has created and provided end-to-end forensic products, solutions, techniques, and technologies for evidence management, cyber/digital forensics, fingerprint science, crime scene investigation, and social media analytics since FY2015.
Kwick Forensic Solutions IPO Details
The Kwick Forensic Solutions IPO date of opening is 27 Aug 2026; its initial public offering will end on 31 Aug, IPO allotment on Sep 01 and refund initiation on Sep 02, 2026.
The Rs. 50.77 crore new SME IPO comprises a combination of a fresh issue of 0.46 crore shares (Rs. 41.05 Cr) and an offer for sale of 0.11 crore shares (Rs. 9.72 Cr).
The Kwick Forensic Solutions IPO listing date (expected) might be Thursday, Sep 03, 2026, and the listing on the BSE and SME.
The Kwick Forensic Solutions IPO price band is Rs. 85 to Rs. 90.
IPO Timetable (Tentative)
|
Events |
Date |
|
IPO Opening Date |
Aug 27, 2026 |
|
IPO Closing Date |
Aug 31, 2026 |
|
IPO Allotment Date |
Sep 01, 2026 |
|
Refund Initiation |
Sep 02, 2026 |
|
IPO Listing Date |
Sep 03, 2026 |
Click to open demat account and apply for the IPO.
Company Financials
(Amount in Cr)
|
Particulars |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|
Assets |
60.53 |
46.79 |
19.19 |
|
Total Income |
105.80 |
65.08 |
30.26 |
|
Profit After Tax |
13.51 |
8.56 |
2.83 |
|
EBITDA |
19.06 |
12.25 |
5.45 |
|
Net Worth |
41.41 |
27.90 |
9.86 |
|
Reserves and Surplus |
24.53 |
25.79 |
7.93 |
|
Total Borrowing |
- |
3.26 |
3.24 |
Cash Flows
(Amount in Lac)
|
Net Cash Flow |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|
Net Cash Flow Operating Activities |
762.30 |
465.09 |
(260.57) |
|
Net Cash Flow Investing Activities |
(273.17) |
(97.40) |
(40.21) |
|
Net Cash Flow Financing Activities |
(379.60) |
835.59 |
(86.61) |
Revenue Bifurcation
(Rs. in Lac)
(Source: RHP)
The Objective of the Issue
The Company desires to use the Net Proceeds from the Issue to fulfill its following goals:
-
Funding the working capital requirements of the Company. ~ Rs. 31.42 Cr.
-
General Corporate Purposes.
Listed Peers of Kwick Forensic Solutions Ltd.
No listed peer of a similar size is engaged in the same lines of business as mentioned in the RHP.
Valuation
|
KPI |
Value (Mar 31, 2026) |
|
ROE |
38.98% |
|
ROCE |
44.88% |
|
Debt/Equity |
- |
|
RoNW |
32.62% |
|
PAT Margin |
12.78% |
|
EBITDA Margin |
18.03% |
Evaluation of P/E Ratio
Considering the period ended on FY 2026 with an EPS of Rs. 8 from the last year, the resulting P/E ratio is 11.25x.
Explore the Optimystix Entertainment IPO.
IPO's Strengths
-
End-to-end forensic science and evidence-management solutions.
-
Diversified portfolio covering physical, digital, cyber and DNA forensics.
-
Strategic relationships and tie-ups with global forensic technology providers.
-
Focus on niche forensic and law-enforcement market segments.
-
In-house R&D and development of forensic handheld devices and solutions.
IPO's Weaknesses
-
The company’s products and services are significantly concentrated in certain states, particularly Bihar and Gujarat. Any adverse developments in these regions may materially impact its business.
-
The company is dependent on a limited number of suppliers for procurement of its raw materials, and the loss of any one or more of the major suppliers would have a material adverse effect on its business operations.
-
Delays in execution of its orders may lead to cost escalation and adversely affect its financial performance.
Kwick Forensic Solutions IPO GMP
Kwick Forensic Solutions IPO GMP today is Rs. 43 as of 22 August 2026, while writing this information.
Kwick Forensic Solutions IPO Summary
|
IPO Opening & Closing Date |
27 Aug, 2026 to 31 Aug, 2026 |
|
Face Value |
Rs. 10 per Share |
|
Issue Price |
Rs. 85 to Rs. 90 per Share. |
|
Lot Size |
1600 Shares |
|
Issue Size |
56,41,600 Shares (Rs. 51 Cr) |
|
Offer for Sale |
10,80,000 Shares (Rs. 10 Cr) |
|
Fresh Issue |
42,78,400 Shares (Rs. 39 Cr) |
|
Listing at |
BSE, SME |
|
Issue Type |
Bookbuild Issue |
|
Registrar |
Bigshare Services Pvt. Ltd. |
IPO Lot Details
Retail investors can invest in a minimum and maximum of 2 Lots (3200 Shares) for Rs. 2,88,000, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (4800 Shares) for Rs. 4,32,000.
|
Minimum Lot Investment (Retail) |
2 Lots |
|
Maximum Lot Investment (Retail) |
2 Lots |
|
HNI (Min) |
3 Lots |
Kwick Forensic Solutions IPO Allotment Status
To check the Kwick Forensic Solutions IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.
Using BSE Website - BSE IPO allotment status
Promoters And Management of Kwick Forensic Solutions Ltd.
-
Shammer Saralal Shah
-
Sejal Shammer Shah
-
Tulsidas Hinduja
-
Ashok Kumar.
|
Pre-Issue Promoter Shareholding |
88.54% |
|
Post-Issue Promoter Shareholding |
64.65% |
IPO Lead Managers
Corporate Capital Ventures Pvt. Ltd.
Dividend Policy
The company has not paid a dividend in any year.
Conclusion
Kwick Forensic Solutions IPO, a ₹50.77 Cr SME issue specializing in forensic science, cyber forensics, and law-enforcement solutions, opens from 27 to 31 August 2026 at a price band of ₹85–₹90. With strong revenue growth, high ROE, and proceeds focused on working capital, the IPO offers exposure to India’s niche forensic and digital investigation market.
Other Related Blogs:-
Gulf Lloyds IPO
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To read the Prospectus of the company, click here to download the DRHP.
Click Here To Stay Updated With The Upcoming IPOs.
DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and informational purposes only. Always consult your eligible financial advisor for investment-related decisions.
